Structure-based lead optimization of novel bacterial type II topoisomerase inhibitors

被引：0
|
作者：
Pearson, Neil D.
Yang, Zheng
Bax, Benjamin D.
Gwynn, Michael N.
机构：
[1] GlaxoSmithKline Inc, Dept Antibacterial Chem, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[2] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Collegeville, PA USA
[3] GlaxoSmithKline Inc, Dept Antibacterial Microbiol, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[4] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
381-COMP
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin
    Hartman, Alwin M.
    Mondal, Milon
    Radeva, Nedyalka
    Klebe, Gerhard
    Hirsch, Anna K. H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (08): : 19184 - 19194
  • [42] Structure-guided design and optimization of fluoroquinolone-substituted bacterial type IIA DNA topoisomerase inhibitors
    Thalji, Reema
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [43] Bacterial diversity based on type II DNA topoisomerase genes
    Huang, WM
    ANNUAL REVIEW OF GENETICS, 1996, 30 : 79 - 107
  • [44] Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
    da Silva, Elany Barbosa
    Rocha, Debora A.
    Fortes, Isadora S.
    Yang, Wenqian
    Monti, Ludovica
    Siqueira-Neto, Jair L.
    Caffrey, Conor R.
    McKerrow, James
    Andrade, Saulo F.
    Ferreira, Rafaela S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (17) : 13054 - 13071
  • [45] Structure-Based Optimization of TBK1 Inhibitors
    Sun, Wenxuan
    Xie, Yuting
    Xia, Qiancheng
    Wang, Yuanxun
    Qi, Xiangbing
    Huang, Niu
    ACS MEDICINAL CHEMISTRY LETTERS, 2025,
  • [46] Docking of Protein Kinase B Inhibitors: Implications in the Structure-Based Optimization of a Novel Scaffold
    Hernandez-Campos, Alicia
    Velazquez-Martinez, Israel
    Castillo, Rafael
    Lopez-Vallejo, Fabian
    Jia, Ping
    Yu, Yongping
    Giulianotti, Marc A.
    Medina-Franco, Jose L.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 76 (03) : 269 - 276
  • [47] Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay
    Yu, Rao
    Cheng, Li Ping
    Li, Meng
    Pang, Wan
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12): : 1667 - 1673
  • [48] Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase
    Tondi, D
    Slomczynska, U
    Costi, MR
    Watterson, DM
    Ghelli, S
    Shoichet, BK
    CHEMISTRY & BIOLOGY, 1999, 6 (05): : 319 - 331
  • [49] Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors
    Li, Hui
    Tatlock, John
    Linton, Angelica
    Gonzalez, Javier
    Borchardt, Allen
    Dragovich, Peter
    Jewell, Tanya
    Prins, Tom
    Zhou, Ru
    Blazel, Julie
    Parge, Hans
    Love, Robert
    Hickey, Michael
    Doan, Chau
    Shi, Stephanie
    Duggal, Rohit
    Lewis, Cristina
    Fuhrman, Shella
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4834 - 4838
  • [50] Structure-based lead optimisation of kinase inhibitors:: facts or fantasy?
    Müller, G
    FEBS JOURNAL, 2005, 272 : 521 - 521
12345